Biofluids manipulation methods for liquid biopsy in minimally-invasive assays
- PMID: 35774416
- PMCID: PMC9237943
- DOI: 10.1016/j.mex.2022.101759
Biofluids manipulation methods for liquid biopsy in minimally-invasive assays
Abstract
The Liquid Biopsy (LB) is an opportunity for non-invasive diagnosis and prognosis of various diseases. To date, it isn't possible to consider that tissue biopsy can represent a pathology entirety. Then, body fluids are rich in a large number and variety of biomarkers and they can provide information about several diseases.•Recently, other biological fluids, easy to be collected are rising for their significant content of biomarkers and for the possibility to collect and manipulate them without the intervention of medical staff.•The management of biological fluids requires suitable storage methods. Temperature, storage time and physical stresses due to sample handling can lead to chemical and physical changes that may induce sample degradation and incorrect analysis.•The reliability of a diagnostic or screening test depends on its sensitivity and specificity. As the liquid biopsy is a 'snapshot' of a pathophysiological condition, it is crucial that its components do not degrade due to the improper handling of the body fluid.In this review, some handling methods of Saliva, Urine, Stool, Seminal Fluid, Tears and Sweat samples will be described, as well as protocols to facilitate the analysis of metabolites, nucleic acids, proteins and Extracellular Vesicles (EVs) from those unusual body fluids.
Keywords: Biomarkers; Body fluid; Diagnosis; Sample handling; Screening.
© 2022 The Authors. Published by Elsevier B.V.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Dong X., Zheng T., Zhang M., Dai C., Wang L., Wang L., Zhang R., Long Y., Wen D., Xie F., Zhang Y., Huang Y., Dong J., Liu H., Du P., King B.L., Tan W., Jia S., Lu C.X., Kohli M., Wang H., Yu J. Circulating cell-free DNA-based detection of tumor suppressor gene copy number loss and its clinical implication in metastatic prostate cancer. Front. Oncol. 2021;11:1–7. doi: 10.3389/fonc.2021.720727. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
